Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the hemoglobin a1c (hba1c) testing market grown over the years?

The market size of Hemoglobin A1c (HbA1c) testing has seen significant growth lately. The market, valued at $1.83 billion in 2024, is projected to reach $2.03 billion in 2025, expanding at a compound annual growth rate (CAGR) of 10.7%. Factors driving this growth in the historical period include higher occurrences of diabetes, increased awareness and screening programs, improved government endeavors and healthcare protocols, developing healthcare infrastructure, a rising elderly population, enhanced diagnostic precision, and a higher uptake of point-of-care testing.

What Is the forecasted market size and growth rate for the hemoglobin a1c (hba1c) testing market?

In the coming years, the hemoglobin a1c (HbA1c) testing market is predicted to experience a swift expansion. The market is projected to surge to $3.02 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. Several factors contribute to this projected growth in the forecast period, including a rising number of lifestyle diseases, the growing emphasis on preventive healthcare, the continued development in emerging markets, increased use of personalized medicine and patient-focused treatment, supportive regulations and reimbursement policies, and a rise in telemedicine and remote monitoring. The prediction for this period also notes some key trends such as technological advancements, seamless integration with digital health platforms, progress in non-invasive testing technologies, growth in telehealth, and advancements in remote patient monitoring techniques.

Get your hemoglobin a1c (hba1c) testing market report here!

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

What are the major factors driving growth in the hemoglobin a1c (hba1c) testing market?

The escalating occurrence of diabetes is anticipated to boost the progression of the hemoglobin A1c (HbA1c) testing market in the future. Diabetes, a long-term health issue, is a condition where the human system fails to control blood sugar levels effectively due to a lack of adequate insulin or insulin resistance. The surge in diabetes cases can be attributed to poor dietary habits, primarily the overconsumption of processed foods and sugar-laden beverages, and inactive lifestyles marked by limited physical activity. In addition, older age groups and hereditary diabetes also heighten the likelihood of acquiring the disease. HbA1c testing serves as a tool for assessing long-term blood sugar control in diabetic individuals by determining the mean blood sugar level over the past 2–3 months. For example, in June 2023, The Lancet, a book publisher and periodic data disseminator based in the UK, predicted that global diabetes instances will rise from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing incidence of diabetes is set to fuel the growth of the hemoglobin A1c (HbA1c) testing market.

What key areas define the segmentation of the global hemoglobin a1c (hba1c) testing Market?

The hemoglobin a1c (HbA1c) testing market covered in this report is segmented –

1) By Type: Laboratory Based Testing, Point Of Care (PoC) Testing

2) By Product Type: Instruments, Reagents, Kits

3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography, Other Technologies

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings, Other End Users

Subsegments:

1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry

2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits, Home Use Hba1c Monitoring Devices, Wireless Hba1c Testing Solutions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

What are the top market players propelling the growth of the hemoglobin a1c (hba1c) testing industry?

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

What emerging trends are influencing the growth of the hemoglobin a1c (hba1c) testing market?

Key companies in the hemoglobin A1c (HbA1c) testing market are honing in on the development of technologically advanced diagnostic tools, including HbA1c home testing kits. These kits provide a more flexible, precise, and readily available method to identify and control diabetes early on. Home testing for HbA1c provides people the opportunity to evaluate their average blood glucose levels from the past 2-3 months, assisting in the surveillance and regulation of diabetes. For example, in February 2023, Hurdle Health, a company from the USA that gives innovative healthcare solutions including chronic illness diagnostic tools, introduced the Hemoglobin A1c (HbA1c) Test. This recent test for home blood sampling allows adults to examine and track diabetes, pushing forward Chronomics’ aim of increasing accessibility to diagnostic testing and improving health outcomes through consumer-targeted solutions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18632

What regions are dominating the hemoglobin a1c (hba1c) testing market growth?

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hemato Oncology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: